Close

Form 6-K GLAXOSMITHKLINE PLC For: Nov 14

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


November 14, 2014 12:48 PM EST

FORM 6-K
�
�
SECURITIES AND EXCHANGE COMMISSION(
Washington D.C. 20549
�
�
Report of Foreign Issuer
�
�
Pursuant to Rule 13a-16 or 15d-16 of(
the Securities Exchange Act of 1934
�
�
�
For period ending�November 2014
�
GlaxoSmithKline plc
(Name of registrant)(

�
�
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)(

�
�
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F(

�
�
Form 20-F x��� �Form 40-F(
�
--(
�
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.(

�
�
Yes����� No x
--
�
�
�

GlaxoSmithKline plc
�
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
�
�
In accordance with DTR 3.1.4R(1)(a)I give below details of changes in the interests of Mr N Hirons, a Person Discharging Managerial Responsibilities, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):
�
The exercise of options over 3,570 GSK American Depositary Shares ('ADSs') on 12 November 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of $43.73 per ADS, and the sale of 2,286 and 1,284 GSK ADSs at a price of $45.70 and $45.72 per ADS respectively, on 12 November 2014.
�
The Company was advised of the transaction on 14 November 2014.
�
�
V A Whyte
Company Secretary
�
14 November 2014
�

�

�
�
SIGNATURES
�
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.(


�
�
GlaxoSmithKline plc
(Registrant)(

Date:�November 14,�2014�
�
�
By:�VICTORIA WHYTE
----------------------
�
�
Victoria�Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings